The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.

The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.
复制标题

DOI:
10.1016/j.vaccine.2011.07.140
复制
发表时间:
2011-10-13
期刊:
影响因子:
5.5
通讯作者:
Jacobs, Bertram L.
Jacobs, Bertram L.
中科院分区:
医学3区
文献类型:
--
作者:
Denzler, Karen L.;Rice, Amanda D.;MacNeill, Amy L.;Fukushima, Nobuko;Lindsey, Scott F.;Wallace, Greg;Burrage, Andrew M.;Smith, Andrew J.;Manning, Brandi R.;Swetnam, Daniele M.;Gray, Stacey A.;Moyer, R. W.;Jacobs, Bertram L.

文献摘要

参考文献

被引文献

相似文献

Vaccinia virus deleted for the innate immune evasion gene, E3L, has been shown to be highly attenuated and yet induces a protective immune response against challenge by homologous virus in a mouse model. In this manuscript the NYCBH vaccinia virus vaccine strain was compared to NYCBH vaccinia virus deleted for E3L (NYCBHΔE3L) in a rabbitpox virus (RPV) challenge model. Upon scarification, both vaccines produced a desired skin lesion, although the lesion produced by NYCBHΔE3L was smaller. Both vaccines fully protected rabbits against lethal challenge by escalating doses of RPV, from 10 LD50 to 1,000 LD50. A single dose of NYCBHΔE3L protected rabbits from weight loss, fever, and clinical symptoms following the lowest dose challenge of 10 LD50, however it allowed a moderate level of RPV replication at the challenge site, some spread to external skin and mucosal surfaces, and increased numbers of secondary lesions as compared to vaccination with NYCBH. Alternately, two doses of NYCBHΔE3L fully protected rabbits from weight loss, fever, and clinical symptoms, following challenge with 100 to 1,000 LD50 RPV, and it prevented development of secondary lesions similar to protection seen with NYCBH. Finally, vaccination with either one or two doses of NYCBHΔE3L resulted in similar neutralizing antibody titers following RPV challenge as compared to titers obtained by vaccination with NYCBH. These results support the efficacy of the attenuated NYCBHΔE3L in protection against an orthologous poxvirus challenge.
DOI: 10.1099/0022-1317-50-1-89
发表时间: 1980-01-01
影响因子: 3.8
作者:
PAYNE, LG
通讯作者: PAYNE, LG
DOI: 10.1099/vir.0.81331-0
发表时间: 2005-11-01
影响因子: 3.8
作者:
Li, G;Chen, N;Upton, C
通讯作者: Upton, C
DOI: 10.1128/jvi.00423-07
发表时间: 2007-10-01
影响因子: 5.4
作者:
Adams, Mathew M.;Rice, Amanda D.;Moyer, R. W.
通讯作者: Moyer, R. W.
DOI: 10.1016/j.vaccine.2009.06.105
发表时间: 2009-09-04
期刊: Vaccine
影响因子: 5.5
作者:
Garza NL;Hatkin JM;Livingston V;Nichols DK;Chaplin PJ;Volkmann A;Fisher D;Nalca A
通讯作者: Nalca A
DOI: 10.1517/13543784.17.4.555
发表时间: 2008-04-01
影响因子: 6.1
作者:
Greenberg, Richard N.;Kennedy, Jeffrey S.
通讯作者: Kennedy, Jeffrey S.